Social networking helpful for patients, but may need to be vetted
Many social media sites exist, but healthcare professionals may not know that social media also exists in their realm. It ranges from online medical advice to actual patient-physician appointments.read...
View ArticleSpecialty pharmacy management strategies continually updated
Costs for specialty pharmaceuticals continue to increase at double-digit rates. Therefore key stakeholders such as pharmacy benefit management companies, health plans, specialty pharmacies,...
View ArticleInterventions can help curb adverse drug events
Overall, 70% of adverse drug events are considered preventable. Since managed care companies are always looking to improve patient care and prevent adverse outcomes, it is no wonder that patient safety...
View ArticleDrug Watch: Agents in late-stage development for the treatment of female and...
Agents in late-stage development for the treatment of female and male cancers.read more
View ArticleDrug Watch: Eye diseases (PDF) (December 2010)
Agents in late-stage development for the treatment of eye diseases.read more
View ArticleGreater vigilance needed for unapproved agents; reduce demand for these drugs...
Removal of marketed unapproved drugs (MUDs), such as that with oral colchicine, is part of FDA's Unapproved Drugs Initiative (launched in 2006).read more
View ArticleManagement with specialty pharmaceuticals imminent for various conditions
Specialty pharmaceuticals are expected to eventually replace non-specialty agents for the management of various conditions, including gout, lupus, diabetes, and hypercholesterolemia.read more
View ArticleThe non-specialty pharmaceutical pipeline: What's on the horizon?
About half of the top non-specialty drugs will become generic within the next 5 years, therefore the trend is for pharmaceutical companies to search and "co-develop" agents rather than investing large...
View ArticleDrug Watch: Cystic fibrosis (PDF) (February 2011)
Agents in late-stage development of cystic fibrosisread more
View ArticleDrug Watch: Major depressive disorder and generalized anxiety disorder (PDF)...
Agents in late-stage development of major depressive disorder and generalized anxiety disorder.read more
View ArticleSpecialty drug approvals trend upward; biobetters gain momentum
Within the next 5 years approximately $100 billion will be lost on previous blockbuster brands that will lose (or lost) patent protection. For manufacturers to enhance their return on investment, they...
View ArticleDrug Watch: Psychiatric conditions (PDF) (June 2011)
Agents for use in psychiatric conditions.read more
View ArticleDrug Watch: AIDS, HIV infection, and related complications (PDF) (August 2011)
Agents for use for AIDS, HIV infection, and related complications.read more
View ArticleDrug Watch: Immune-mediated diseases? rheumatoid arthritis, psoriatic...
Agents for use in immune-mediated diseases?rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis.read more
View Article
